As the debate about “strategic” vs. “transactional” relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player

As the debate about “strategic” vs. “transactional” relationship between Pharma and CROs goes on, we thought that you might enjoy a viewpoint of an independent regional player.

Please follow the link to the whitepaper that may provide some additional insight into this contentious issue.